Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
25.12.24
/
50%
€20.76
Target price
25.12.25
-
Performance (%)
-14.50%
Price
19:20
€17.75
Summary
This prediction is currently active. The prediction for Catalyst Pharmaceutical Partners Inc disappoints with a performance of -14.50%. This prediction currently runs until 25.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Catalyst Pharmaceutical Partners Inc | -1.598% | -1.598% |
iShares Core DAX® | -0.693% | 2.143% |
iShares Nasdaq 100 | -1.173% | 1.632% |
iShares Nikkei 225® | -1.388% | 2.138% |
iShares S&P 500 | -1.411% | 0.648% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€17.43
12.10.25
12.10.25
-
12.10.26
12.10.26
0.00%
19:20
19:20
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€16.81
21.09.25
21.09.25
-
21.09.26
21.09.26
5.62%
19:20
19:20
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€21.73
11.01.25
11.01.25
-
11.01.26
11.01.26
-19.79%
19:20
19:20
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.62
04.01.25
04.01.25
-
04.01.26
04.01.26
-15.47%
19:20
19:20
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.43
08.06.24
08.06.24
-
08.06.25
08.06.25
59.39%
09.06.25
09.06.25